Clinical Trials
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Diabetes
FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study for Pediatric Patients
- Ages4 years - 17 years
- GenderBoth
- Obesity & Weight Management
Yale Dietary Supplement and Weight Management Study
- Ages18 years - 55 years
- GenderBoth